Abstract
An increased potential patient pool due to the aging European population and a
strong desire of physicians to treat atrial fibrillation will drive procedure
volumes. Driving growth in the market will be the adoption of advanced
technologies to treat complex arrhythmias such as atrial fibrillation and
ventricular tachycardia. Counter to drivers of the EP market will be
healthcare budget constraints in Europe that limit hospital spending and a low
supply of hospital infrastructure to expand EP lab space.
Product coverage includes electrophysiology (EP) lab systems (X-ray, EP
recording systems, 3-D mapping systems, Intracardiac Echocardiography (ICE)
systems), EP diagnostic catheters (conventional and advanced) and EP ablation
catheters (conventional and advanced).
View Cart
